Alvio

Alvion Pharmaceuticals is a fully integrated pharmaceutical company based in Greece, specializing in the development and commercialization of Value Added Medicines (VAMs) and complex generic products. The company focuses on enhancing existing therapeutic molecules through innovative formulations and combinations to improve patient outcomes and address unmet medical needs. Alvion maintains a robust pipeline across diverse therapeutic areas, including cardiovascular, central nervous system (CNS), and oncology. By leveraging a strong network of international partnerships, the company successfully licenses and distributes its products across European and global markets. Alvion's business model emphasizes research-driven development and high-quality manufacturing standards to provide cost-effective healthcare solutions.